Process View
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ketone stimulus.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "response to ketone"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| EGFR | epidermal growth factor receptor | 0.985 | ||
| ESR1 | estrogen receptor 1 | 0.984 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.953 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.730 | ||
| NRP1 | neuropilin 1 | 0.498 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.395 | ||
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 0.372 | Rat | |
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.363 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.278 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.277 | ||
| CCR5 | chemokine (C-C motif) receptor 5 | 0.267 | ||
| HDAC1 | histone deacetylase 1 | 0.259 | ||
| JUN | jun proto-oncogene | 0.224 | ||
| ARRB1 | arrestin, beta 1 | 0.219 | ||
| JAK2 | Janus kinase 2 | 0.212 | Mouse | |
| NCOA1 | nuclear receptor coactivator 1 | 0.186 | ||
| CASP3 | caspase 3, apoptosis-related cysteine peptidase | 0.174 | ||
| NOSTRIN | nitric oxide synthase trafficker | 0.164 | ||
| THBS1 | thrombospondin 1 | 0.161 | ||
| CREBBP | CREB binding protein | 0.157 | ||
| GSTM4 | glutathione S-transferase mu 4 | 0.154 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.152 | ||
| PLAU | plasminogen activator, urokinase | 0.151 | ||
| CCL2 | chemokine (C-C motif) ligand 2 | 0.133 | Human | |
| PCGF2 | polycomb group ring finger 2 | 0.128 | ||
| AXL | AXL receptor tyrosine kinase | 0.121 | ||
| CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.105 | ||
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.104 | ||
| XIAP | X-linked inhibitor of apoptosis | 0.103 | ||
| CCL4 | chemokine (C-C motif) ligand 4 | 0.103 | Human | |
| APP | amyloid beta (A4) precursor protein | 0.095 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.090 | ||
| ENG | endoglin | 0.086 | Human | |
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.085 | Rat | |
| IL6 | interleukin 6 (interferon, beta 2) | 0.081 | ||
| APAF1 | apoptotic peptidase activating factor 1 | 0.077 | ||
| CXCL9 | chemokine (C-X-C motif) ligand 9 | 0.076 | ||
| JUNB | jun B proto-oncogene | 0.075 | ||
| NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.068 | ||
| RARA | retinoic acid receptor, alpha | 0.065 | ||
| NRIP1 | nuclear receptor interacting protein 1 | 0.063 | ||
| EP300 | E1A binding protein p300 | 0.059 | ||
| PTEN | phosphatase and tensin homolog | 0.059 | ||
| DPP4 | dipeptidyl-peptidase 4 | 0.057 | ||
| GSTM2 | glutathione S-transferase mu 2 (muscle) | 0.056 | ||
| LAT | linker for activation of T cells | 0.053 | ||
| ALDH1A1 | aldehyde dehydrogenase 1 family, member A1 | 0.053 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.049 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.047 | ||
| CXCL10 | chemokine (C-X-C motif) ligand 10 | 0.047 | ||
| STAT5A | signal transducer and activator of transcription 5A | 0.045 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.045 | ||
| CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.045 | ||
| ATF3 | activating transcription factor 3 | 0.044 | ||
| ICAM1 | intercellular adhesion molecule 1 | 0.043 | ||
| IRS1 | insulin receptor substrate 1 | 0.041 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.040 | Rat | |
| DNMT3A | DNA (cytosine-5-)-methyltransferase 3 alpha | 0.040 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.040 | ||
| VEZF1 | vascular endothelial zinc finger 1 | 0.039 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.039 | ||
| CDK2 | cyclin-dependent kinase 2 | 0.038 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.038 | ||
| RNF144B | ring finger protein 144B | 0.038 | ||
| MYD88 | myeloid differentiation primary response gene (88) | 0.037 | ||
| STAT3 | signal transducer and activator of transcription 3 (acute-phase response factor) | 0.037 | ||
| CTTN | cortactin | 0.036 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.035 | ||
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.033 | Rat | |
| PLAT | plasminogen activator, tissue | 0.033 | Rat | |
| UHRF1 | ubiquitin-like with PHD and ring finger domains 1 | 0.032 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.032 | ||
| CCL19 | chemokine (C-C motif) ligand 19 | 0.032 | ||
| SPDEF | SAM pointed domain containing ets transcription factor | 0.031 | ||
| RNR2 | l-rRNA | 0.031 | ||
| MAPK14 | mitogen-activated protein kinase 14 | 0.031 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.031 | ||
| CCL18 | chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated) | 0.030 | Human | |
| CDK6 | cyclin-dependent kinase 6 | 0.030 | ||
| TIRAP | toll-interleukin 1 receptor (TIR) domain containing adaptor protein | 0.030 | ||
| CXCL11 | chemokine (C-X-C motif) ligand 11 | 0.029 | ||
| CSF1 | colony stimulating factor 1 (macrophage) | 0.029 | ||
| SMPD1 | sphingomyelin phosphodiesterase 1, acid lysosomal | 0.029 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.029 | ||
| BCL2L1 | BCL2-like 1 | 0.029 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.029 | Rat | |
| EIF3F | eukaryotic translation initiation factor 3, subunit F | 0.029 | ||
| JDP2 | Jun dimerization protein 2 | 0.028 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.027 | ||
| EDF1 | endothelial differentiation-related factor 1 | 0.027 | ||
| CCL8 | chemokine (C-C motif) ligand 8 | 0.026 | Human | |
| IER2 | immediate early response 2 | 0.026 | ||
| IL8 | interleukin 8 | 0.025 | ||
| CCR7 | chemokine (C-C motif) receptor 7 | 0.025 | ||
| IDE | insulin-degrading enzyme | 0.024 | ||
| EED | embryonic ectoderm development | 0.024 | ||
| MSTO1 | misato homolog 1 (Drosophila) | 0.024 | ||
| DARC | Duffy blood group, chemokine receptor | 0.023 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.022 | ||
| FSTL1 | follistatin-like 1 | 0.022 | ||
| CCL13 | chemokine (C-C motif) ligand 13 | 0.022 | Human | |
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.022 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.022 | ||
| RERE | arginine-glutamic acid dipeptide (RE) repeats | 0.021 | ||
| PHC1 | polyhomeotic homolog 1 (Drosophila) | 0.021 | Fly | |
| EGR1 | early growth response 1 | 0.021 | ||
| CRHR1 | corticotropin releasing hormone receptor 1 | 0.021 | ||
| PRMT2 | protein arginine methyltransferase 2 | 0.021 | ||
| EPOR | erythropoietin receptor | 0.021 | ||
| NIPBL | Nipped-B homolog (Drosophila) | 0.021 | ||
| SCMH1 | sex comb on midleg homolog 1 (Drosophila) | 0.021 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.021 | ||
| IFNG | interferon, gamma | 0.020 | ||
| ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | 0.020 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.020 | ||
| CBX4 | chromobox homolog 4 | 0.020 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.020 | ||
| CUEDC2 | CUE domain containing 2 | 0.020 | ||
| S100B | S100 calcium binding protein B | 0.020 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.020 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.019 | ||
| BAZ1B | bromodomain adjacent to zinc finger domain, 1B | 0.019 | ||
| GABRA3 | gamma-aminobutyric acid (GABA) A receptor, alpha 3 | 0.019 | ||
| RSF1 | remodeling and spacing factor 1 | 0.019 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.019 | ||
| SMAD4 | SMAD family member 4 | 0.018 | ||
| RING1 | ring finger protein 1 | 0.018 | ||
| CCL3 | chemokine (C-C motif) ligand 3 | 0.018 | Human | |
| SOCS3 | suppressor of cytokine signaling 3 | 0.018 | Rat | |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.017 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.017 | ||
| H3F3C | H3 histone, family 3C | 0.017 | ||
| RANBP2 | RAN binding protein 2 | 0.017 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.017 | ||
| CCL11 | chemokine (C-C motif) ligand 11 | 0.017 | Human | |
| CCL7 | chemokine (C-C motif) ligand 7 | 0.017 | Human | |
| VCAM1 | vascular cell adhesion molecule 1 | 0.016 | ||
| CLNS1A | chloride channel, nucleotide-sensitive, 1A | 0.016 | ||
| CXCL13 | chemokine (C-X-C motif) ligand 13 | 0.016 | ||
| NBN | nibrin | 0.016 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.016 | ||
| CCND3 | cyclin D3 | 0.016 | ||
| NR2E3 | nuclear receptor subfamily 2, group E, member 3 | 0.016 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.016 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.016 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.016 | ||
| CCL22 | chemokine (C-C motif) ligand 22 | 0.016 | Human | |
| NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.016 | ||
| CBX8 | chromobox homolog 8 | 0.015 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.015 | ||
| ANKS1B | ankyrin repeat and sterile alpha motif domain containing 1B | 0.015 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.015 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.015 | ||
| ADH1C | alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.015 | ||
| PRKCA | protein kinase C, alpha | 0.014 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.014 | ||
| PRMT6 | protein arginine methyltransferase 6 | 0.014 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.014 | Rat | |
| PRRC2B | proline-rich coiled-coil 2B | 0.014 | ||
| MYLK2 | myosin light chain kinase 2 | 0.014 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.014 | Rat | |
| IL1RN | interleukin 1 receptor antagonist | 0.014 | ||
| SELE | selectin E | 0.014 | ||
| CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.014 | ||
| STAT5B | signal transducer and activator of transcription 5B | 0.014 | ||
| RB1 | retinoblastoma 1 | 0.014 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.013 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.013 | Human | |
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.013 | ||
| BIRC3 | baculoviral IAP repeat containing 3 | 0.013 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.013 | ||
| CCND1 | cyclin D1 | 0.013 | Rat | |
| EIF4E | eukaryotic translation initiation factor 4E | 0.013 | ||
| IL12B | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) | 0.013 | ||
| CXCL5 | chemokine (C-X-C motif) ligand 5 | 0.013 | ||
| NTRK1 | neurotrophic tyrosine kinase, receptor, type 1 | 0.012 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.012 | ||
| SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 0.012 | ||
| GHR | growth hormone receptor | 0.012 | ||
| GPC3 | glypican 3 | 0.012 | ||
| MED13 | mediator complex subunit 13 | 0.012 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.012 | ||
| RPS6KA5 | ribosomal protein S6 kinase, 90kDa, polypeptide 5 | 0.012 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.012 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.012 | ||
| CD83 | CD83 molecule | 0.012 | ||
| CCR4 | chemokine (C-C motif) receptor 4 | 0.012 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.012 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.012 | ||
| INSR | insulin receptor | 0.012 | Rat | |
| MED15 | mediator complex subunit 15 | 0.012 | ||
| KCTD17 | potassium channel tetramerisation domain containing 17 | 0.012 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.011 | ||
| IL1B | interleukin 1, beta | 0.011 | Rat | |
| HBEGF | heparin-binding EGF-like growth factor | 0.011 | ||
| CHD1 | chromodomain helicase DNA binding protein 1 | 0.011 | ||
| ARRDC3 | arrestin domain containing 3 | 0.011 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.011 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.011 | ||
| SOD1 | superoxide dismutase 1, soluble | 0.011 | ||
| DDIT3 | DNA-damage-inducible transcript 3 | 0.011 | ||
| SMAD3 | SMAD family member 3 | 0.011 | ||
| BCL2A1 | BCL2-related protein A1 | 0.011 | ||
| ATF2 | activating transcription factor 2 | 0.011 | ||
| DCN | decorin | 0.011 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.011 | ||
| USP11 | ubiquitin specific peptidase 11 | 0.011 | ||
| ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.010 | ||
| ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.010 | ||
| DHX30 | DEAH (Asp-Glu-Ala-His) box polypeptide 30 | 0.010 | ||
| CLU | clusterin | 0.010 | ||
| LEPR | leptin receptor | 0.010 | ||
| DES | desmin | 0.010 | ||
| PAK3 | p21 protein (Cdc42/Rac)-activated kinase 3 | 0.010 | ||
| FHL3 | four and a half LIM domains 3 | 0.010 | ||
| COMMD1 | copper metabolism (Murr1) domain containing 1 | 0.010 | ||
| LY96 | lymphocyte antigen 96 | 0.010 | ||
| UBD | ubiquitin D | 0.010 | ||
| STC1 | stanniocalcin 1 | 0.010 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.010 |